These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2146084)

  • 1. Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicity.
    Taylor A; Greene J; Eshima D; Dillehay D
    Contrib Nephrol; 1990; 79():21-3. PubMed ID: 2146084
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
    Eshima D; Greene J; Taylor A
    Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
    [No Abstract]   [Full Text] [Related]  

  • 3. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of 99mTc-MAG3 uptake in renal transplant recipients.
    Oei HY; Surachno S; Wilmink JM; van der Schoot JB
    Contrib Nephrol; 1990; 79():113-7. PubMed ID: 2146080
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of the kinetics of the renal tracers 99Tcm-MAG3 and 131I-hippuran.
    Pavía J; Ros D; Piera C; Pavía A; Bassa P; Giralt E; Setoain J
    Nucl Med Commun; 1991 Jun; 12(6):529-37. PubMed ID: 1830943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of renal scintigraphy and clearance with 99mTc-MAG3 and 123I-hippurate in patients with renal disorders.
    Müller-Suur R; Bois-Svensson I; Mesko L
    Contrib Nephrol; 1990; 79():32-5. PubMed ID: 2146087
    [No Abstract]   [Full Text] [Related]  

  • 12. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
    Kengen RA; Meijer S; Beekhuis H; Piers DA
    J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
    Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
    Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats.
    Galinsky RE; Eshima D; Hansen L; Greene J; Dillehay D; Taylor A
    Mech Ageing Dev; 1990 Dec; 56(3):209-22. PubMed ID: 2150974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
    Lee HB; Blaufox MD
    J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.
    Kim CK; Stritzke P; Goldsmith SJ
    J Nucl Med; 1988 Nov; 29(11):1878-9. PubMed ID: 2972816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.